|
|
 |
|
Viewing report
|
|
|
|
Company Financials: OSI Pharmaceuticals
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
OSI Pharmaceuticals (OSI Pharma) is a biotechnology company engaged in the discovery, development, and commercialization of drugs for the treatment of oncology, diabetic and obesity.
The company's flagship product, Tarceva, is an oral, once-a-day, small molecule therapeutic designed to inhibit the receptor tyrosine kinase activity of the protein product of the HER1/EGFR gene.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Inspire Pharmaceuticals
Company Financials: Watson Pharmaceuticals, Inc.
Company Financials: DUSA Pharmaceuticals, Inc.
Company Financials: ISTA Pharmaceuticals, Inc.
Company Financials: Gedeon Richter Plc
Company Financials: Alexza Pharmaceuticals
Company Financials: Sanofi-Aventis SA
Company Financials: Optimer Pharmaceuticals, Inc.
Company Financials: Regeneron Pharmaceuticals, Inc.
Company Financials: POZEN, Inc.
|
|
|
|
